Hunter Biden says his father was on Ambien before 2024 debate disaster: ‘A deer in headlights'
'I know exactly what happened in that debate,' Hunter told YouTube personality Andrew Callaghan in an interview released on Monday.
'He flew around the world. He's 81 years old. He's tired. They give him Ambien to be able to sleep and he gets up on the stage and looks like a deer in the headlights.'
The veteran Democrat cut a frail figure when he took to the CNN debate stage in Atlanta, Georgia, on June 27 last year to battle it out with Trump as he sought another four years in the White House.
Biden went on to give a series of mangled answers, failing to make the case for his record in the Oval Office or a second term and at one point declared incoherently: 'We finally beat Medicare.'
'I really don't know what he said at the end of that sentence,' his Republican opponent said after one garbled answer. 'I don't think he knows what he said either.'
After more than three weeks of pressure from panicked Democrats for Biden to step aside, he finally did so on July 21, paving the way for then-vice president Kamala Harris to run in his stead, only for her to lose to Trump the following November.
While the use of Ambien is common for sleep disorders, there was no mention of it among the six medications prescribed to the Democrat that were referenced in his annual physical report published on February 28 2024, signed off by Biden's presidential physician Dr. Kevin O'Connor.
In the same interview, Hunter noted that there was little opposition to Biden running again prior to the televised head-to-head: 'The people who came out against him were nobody, except… Speaker Emeritus [Nancy] Pelosi did not give a full-throated endorsement.
'The entirety of the progressive side of the Democratic Party said Joe Biden has got more of our agenda accomplished in four years than any president in history.'
That changed in the aftermath of his father's very public humiliation, Hunter alleged. 'They said, 'We are going to blow up the party if you don't drop out. We're going to protest this all the way up for the next month, all the way up to the convention.''
Picking up his father's story, Hunter told Callaghan: 'He gets over the hump, he goes and does the [ABC News anchor George] Stephanopoulos [interview]. Everybody goes, 'OK, that's not enough, we got to see him give a press conference.''
What followed was another troubling public appearance on July 12 at which Biden appeared alongside Ukrainian President Volodymyr Zelensky and accidentally referred to him as 'Vladimir,' apparently confusing him with Russian President Vladimir Putin.
Five days after that, with the pressure campaign on him to step aside only intensifying, Biden was diagnosed with Covid-19.
'He woke up in the morning and he had a severe case of Covid, and the pictures of him getting on and off the plane were just devastating, and then the vultures descended,' Hunter remembered.
'So Joe Biden, I think, did the most selfless thing that I know of any politician in the history of this f***ing country. He stepped aside to save the party.'
In the same interview, Hunter lashed out at Hollywood actor George Clooney who wrote a New York Times editorial last year calling on the president to drop out of the race after becoming concerned by his appearance at a charity gala alongside Barack Obama.
'F*** you. What do you have to do with f***ing anything?' Hunter said angrily of Clooney.
While the president's son made his opinion clear on why the Democratic ticket failed at the polls last year, others have pointed to his own role in bringing down his father's presidency.
A lightning rod for MAGA conspiracy theories, Hunter's prosecution on tax and gun charges led to speculation that the president would pardon his son, which he denied – and then did anyway – leading some to feel he had received favorable treatment because of his privileged position.
The book 2024: How Trump Retook the White House and the Democrats Lost America by Josh Dawsey, Tyler Pager and Isaac Arnsdorf argues that Biden was preoccupied with the prospect of his son going to prison at the height of election campaigning last summer, causing him to take his eye off the ball.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Pacific Mind Health Releases 5-Minute Mental Health Check-In Toolkit
This simple, evidence-informed practice helps users reduce stress, build self-awareness, and take meaningful steps toward better mental health — all you need is 5 minutes LONG BEACH, Calif., July 28, 2025 /PRNewswire/ -- Got five minutes for your mental health? That's all it takes to start building awareness and making real changes in how you think, feel, and care for your well-being. Pacific Mind Health, a leading provider of outpatient psychiatry and therapy services in California, recently released the 5-Minute Check-In, a downloadable toolkit designed to help individuals develop greater self-awareness. To access the toolkit, visit 5-Minute Check-In. "Taking the time to sit quietly can have a tremendous impact on one's mental wellness," says Pacific Mind Health's supervising clinical psychotherapist Veronica Calkins, LCSW. "Even just a few minutes of intentional awareness can interrupt autopilot thinking, reduce emotional overwhelm, and help you reconnect with what you truly need in the moment." Awareness is a key part of nearly every therapeutic approach, from cognitive behavioral therapy to mindfulness-based practices. A quick self-check-in mimics this effect, allowing you to slow down and reflect on what you're thinking, feeling, and doing. In today's fast-paced world, phone notifications, social media, and packed schedules can drown out your inner voice. Over time, unnoticed habits and emotions can build up and lead to burnout, anxiety, or other mental and physical health challenges. That's where a five-minute awareness check-in can help. How to Practice a Five-Minute Awareness Check-In Pause (30 seconds): Take a deep breath. Close your eyes if possible, and give yourself a moment to relax and be still. Scan your body (1 minute): Notice any physical sensations — tension, fatigue, tightness. Don't try to fix anything. Just observe how your body feels. Observe your thoughts (1 minute): Are your thoughts racing? Are you calm, anxious, or distracted? Notice them without judgment. Name your feelings (1 minute): Try to label your emotions. For example, "I feel nervous," or "I feel content." Naming emotions helps calm the brain and brings clarity. Reflect on your needs (1.5 minutes): Ask yourself what you need to feel more balanced. Maybe it's rest, movement, a glass of water, or a quick chat with a friend. Then, end your check-in by taking one small action to support your needs. Why It Works Regular five-minute check-ins help you stay connected to what's happening mentally, emotionally, and physically. Naming your feelings allows you to pause, think clearly, and reduce emotional overwhelm. When practiced consistently, awareness helps prevent stress from building up and makes it easier to recognize your needs and respond with self-care. "You don't need a perfect routine or hours of free time to care for your mental health," Calkins says. "Small, consistent moments of awareness like a five-minute check-in can build resilience over time and help you stay grounded, even on the busiest days." Want to learn more about how awareness supports mental health? Read the full article Self-Awareness: The First Step Toward Positive Change on our website Pacific Mind Health is a provider of outpatient psychiatry and therapy services in California. With a blend of science and compassion, we create personalized treatment plans to optimize mental health and well-being. CONTACTName: Kim CrossTitle: Vice President of MarketingCompany Name: Pacific Mind HealthEmail: View original content to download multimedia: SOURCE Pacific Mind Health Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15 minutes ago
- Yahoo
Talkspace Announces New In-Network Partnership with Blue Cross of Idaho
Blue Cross of Idaho Members Across All Lines of Business Now Have Access to High-Quality Tele-Mental Healthcare NEW YORK, July 28, 2025--(BUSINESS WIRE)--Talkspace, a leading online behavioral health company, today announced a new in-network partnership with Blue Cross of Idaho to increase behavioral health access across Idaho. As of July 1, 2025, all Blue Cross Idaho members now have access to Talkspace's comprehensive virtual behavioral health services, including support from licensed clinicians through its exclusive asynchronous message-based therapy (featuring voice and video options) as well as live video sessions. "Partnering with Blue Cross of Idaho allows Talkspace to continue our important mission of expanding access to high-quality, convenient mental health care," said Erin Boyd, Chief Growth Officer at Talkspace. "This collaboration will make therapy and psychiatric support affordable for individuals and families across the nation, empowering them to prioritize their mental well-being on their own terms." "Blue Cross of Idaho members deserve access to mental healthcare that fits into their lives," said Dawn Atkin MS, BSN-RN, CPHQ, CCM, Vice President, Healthcare Operations for Blue Cross of Idaho. "That's why we're proud to partner with Talkspace to significantly enhance mental health services for all of our members, providing a direct line to an experienced, licensed professional anytime and anywhere they need support." Blue Cross of Idaho now joins Talkspace's expanding roster of health plans and benefits clients which include Aetna, Carelon, Cigna, Optum and select Blue Cross Blue Shield plans, with Talkspace now covering nearly 200 million lives across the U.S. Talkspace also accepts Medicare and Medicare Advantage for seniors. Talkspace provides licensed therapists across all 50 states and gives members the flexibility to choose live video sessions and asynchronous therapy options. This approach lets users tailor their care to best fit into their busy lives, reducing obstacles to accessing treatment and maximizing engagement. Blue Cross of Idaho members, including couples and teens aged 13+, can register for therapy and psychiatric medication support (18+ only) at About Blue Cross of Idaho Blue Cross of Idaho is part of an Idaho-based, not-for-profit mutual insurance holding company group dedicated to improving the health of the communities we serve. We are the state's oldest and largest health insurer, and the only Idaho-based insurer serving the entire state. Blue Cross of Idaho offers a broad portfolio of health plans for employers of all sizes, as well as individual and Medicare plans. Our plans offer innovative solutions to meet the unique needs of Idahoans and Idaho-based employers. For more information, visit About Talkspace Talkspace (NASDAQ: TALK) is a leading virtual behavioral healthcare provider committed to helping people lead healthier, happier lives through access to high-quality mental healthcare. At Talkspace, we believe that mental healthcare is core to overall health and should be available to everyone. Talkspace pioneered the ability to text with a licensed therapist from anywhere and now offers a comprehensive suite of mental health services, including therapy for individuals, teens, and couples, as well as psychiatric treatment and medication management (18+). With Talkspace's core therapy offerings, members are matched with one of thousands of licensed therapists within days and can engage in live video, audio, or chat sessions, and/or unlimited asynchronous text messaging sessions. All care offered at Talkspace is delivered through an easy-to-use, fully-encrypted web and mobile platform that meets HIPAA, federal, and state regulatory requirements. Most Americans have access to Talkspace through their health insurance plans, employee assistance programs, our partnerships with leading healthcare companies, or as a free benefit through their employer, school, or government agency. For more information, visit View source version on Contacts press@
Yahoo
15 minutes ago
- Yahoo
ReAlta Life Sciences Strengthens Management Team with the Appointment of Biotechnology Business Leader Ellen Lubman, MBA as Chief Business Officer
Accomplished biopharma executive brings nearly 25 years of experience in business development, capital formation, and enterprise strategy to this role NORFOLK, Va., July 28, 2025--(BUSINESS WIRE)--ReAlta Life Sciences, Inc. ("ReAlta" or the "Company"), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute inflammatory diseases, today announced the appointment of Ellen Lubman, MBA as Chief Business Officer. In this role, Ms. Lubman will oversee business development, capital formation and corporate strategy. "Ellen is a highly respected executive with a strong track record of building partnerships, raising capital, and developing successful corporate strategies for biotech and pharmaceutical companies," said David Marek, Chief Executive Officer of ReAlta. "We are excited to welcome Ellen at such a pivotal moment for our business with all three clinical programs reading out this year. Her deep strategic and transactional expertise strengthens our team, and she will play a key leadership role as we forge partnerships with pharmaceutical companies and investors alike to advance our transformative therapies for patients across numerous severe inflammatory diseases with high unmet need." "I am thrilled to join ReAlta and build on the company's accomplishments in developing the EPICC platform and its lead asset pegtarazimod, which has the potential for clarity this year on a path to approval in hypoxic ischemic encephalopathy (HIE), a devastating disease where no pharmacologic treatment exists," said Ms. Lubman. "It is a privilege to contribute to the advancement of this differentiated approach to support the delivery of innovative therapies treating neuroinflammation in newborns with HIE, acute graft-versus-host disease (aGvHD), and acute Chronic Obstructive Pulmonary Disease (COPD)." Ms. Lubman brings seasoned leadership and broad experience across small to large-cap private and public biopharmaceutical companies, with a strong track record in strategic, transactional, and operational roles to ReAlta. She joins ReAlta from Werewolf Therapeutics where she was Chief Business Officer, ushering the company through multiple financings, including an Initial Public Offering, as well as business development transactions. Prior to Werewolf, she was Chief Business Officer of Impel Pharmaceuticals and Vice President of External Science & Innovation at Allergan, where she was responsible for strategic expansion of the company's diverse pipeline of therapeutics in a variety of disease areas. Ms. Lubman has held numerous other executive and leadership roles at Kadmon Pharmaceuticals, Bristol Myers Squibb, Celtic Pharma Management, L.P., Robertson Stephens Investment Bank, and Abbott Labs. She serves on the Board of Directors of Reunion Neuroscience and Cytovation ASA and is a Strategic Advisor to Two Bear Capital. Ms. Lubman earned her M.B.A. from Stanford Graduate School of Business with a focus on Global Management and her B.A. in Biology from Rutgers College. About ReAlta Life Sciences ReAlta Life Sciences, Inc. is a clinical mid-stage biopharmaceutical company dedicated to addressing life threatening rare and acute inflammatory diseases by rebalancing the inflammatory response. The Company's EPICC peptide platform leverages discoveries from the human astrovirus (HAstV-1), which uniquely inhibits components of the innate immune system. ReAlta's therapeutic peptides employ the dual-targeting mechanisms of HAstV-1 to modulate both complement and innate inflammatory pathways by inhibiting complement cascade activation and two key neutrophil-driven mechanisms: myeloperoxidase (MPO) and neutrophil extracellular traps (NETs). The Company's lead candidate, RLS-0071 (pegtarazimod), has received FDA Orphan Drug Designation and Fast Track Designations for hypoxic ischemic encephalopathy (HIE), a devastating disease that causes brain damage and high mortality in oxygen-deprived newborns; Orphan Drug Designation by the European Medicines Agency for HIE; FDA Orphan Drug and Fast Track Designations for acute graft-versus-host disease (aGvHD) associated with bone marrow and stem cell transplants; and FDA IND clearance for acute exacerbations of chronic obstructive pulmonary disease (COPD). Founded in 2018, ReAlta operates in Norfolk, Virginia and Aguadilla, Puerto Rico. For more information, please visit View source version on Contacts Investors John RickmanChief Financial Officerjrickman@ Media Harrison WongICR HealthcareReAltaPR@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data